Last $42.16 USD
Change Today -0.50 / -1.17%
Volume 59.9K
As of 3:37 PM 04/24/14 All times are local (Market data is delayed by at least 15 minutes).

neogen corp (NEOG) Snapshot

Open
$43.06
Previous Close
$42.66
Day High
$43.87
Day Low
$41.69
52 Week High
12/10/13 - $51.22
52 Week Low
04/26/13 - $32.98
Market Cap
1.5B
Average Volume 10 Days
116.4K
EPS TTM
--
Shares Outstanding
36.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NEOGEN CORP (NEOG)

Related News

No related news articles were found.

neogen corp (NEOG) Related Businessweek News

No Related Businessweek News Found

neogen corp (NEOG) Details

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug and pesticide residues, and general sanitation concerns; and AccuPoint, a bioluminescence-based sanitation test for adenosine triphosphate, a chemical found in living cells. It offers its products primarily to food and feed processors, meat and poultry processors, seafood processors, fruit and vegetable producers, grain producers and processors, and dairies; laboratories; producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products; and various regulatory agencies. The Animal Safety segment provides pharmaceuticals, rodenticides, disinfectants, vaccines, veterinary instruments, topicals, diagnostic products, and genetic testing services to the animal safety market. This segment’s drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm animals and racing animals, such as horses, greyhounds, and camels; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. Its products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. In addition, this segment offers various products for researchers to detect biologically-active substances; and proprietary substrates for other diagnostic test kit manufacturers. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing, Michigan.

781 Employees
Last Reported Date: 07/30/13
Founded in 1981

neogen corp (NEOG) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $535.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $227.0K
Vice President of Food Safety Operations
Total Annual Compensation: $216.6K
Vice President of Animal Safety Operations
Total Annual Compensation: $203.1K
Compensation as of Fiscal Year 2013.

neogen corp (NEOG) Key Developments

Neogen Corporation Announces Consolidated Unaudited Earnings Results for the Third Quarter and Nine Months Ended February 28, 2014

Neogen Corporation announced consolidated unaudited earnings results for the third quarter and nine months ended February 28, 2014. For the quarter, the company reported total revenue was $61,996,000 against $51,055,000 a year ago. Operating income was $10,293,000 against $9,666,000 a year ago. Income before tax was $10,253,000 against $10,060,000 a year ago. Net income attributable to company was $6,575,000 against $6,652,000 a year ago. Net income attributable to company per diluted share was $0.18 against $0.18 a year ago. For the nine months, the company reported total revenue was $180,143,000 against $151,522,000 a year ago. Operating income was $32,400,000 against $30,470,000 a year ago. Income before tax was $31,878,000 against $31,014,000 a year ago. Net income attributable to company was $20,621,000 against $20,158,000 a year ago. Net income attributable to company per diluted share was $0.56 against $0.55 a year ago.

Suitors Reportedly Eye Perten

Perten Instruments AB is up for sale. Dagens Industry reported that FOSS A/S, Danaher Corp. (NYSE:DHR), Neogen Corp.(NasdaqGS:NEOG) and Spectris plc (LSE:SXS) are looking at acquiring Perten. Perten is owned by Valedo Partners.

Neogen Corp., Q3 2014 Earnings Call, Mar 25, 2014

Neogen Corp., Q3 2014 Earnings Call, Mar 25, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEOG:US $42.16 USD -0.50

NEOG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biomerica Inc $0.79 USD -0.0242
Meridian Bioscience Inc $20.80 USD -0.92
OraSure Technologies Inc $6.79 USD -0.10
Siemens Ltd 746.90 INR -10.60
Trinity Biotech PLC $23.00 USD -0.17
View Industry Companies
 

Industry Analysis

NEOG

Industry Average

Valuation NEOG Industry Range
Price/Earnings 57.1x
Price/Sales 6.6x
Price/Book 5.4x
Price/Cash Flow 56.6x
TEV/Sales 6.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOGEN CORP, please visit www.neogen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.